GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Meridian Bioscience Inc (FRA:MR4) » Definitions » 12-1 Month Momentum %

Meridian Bioscience (FRA:MR4) 12-1 Month Momentum % : 68.11% (As of May. 14, 2024)


View and export this data going back to 1986. Start your Free Trial

What is Meridian Bioscience 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-14), Meridian Bioscience's 12-1 Month Momentum % is 68.11%.

The industry rank for Meridian Bioscience's 12-1 Month Momentum % or its related term are showing as below:

FRA:MR4's 12-1 Month Momentum % is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: -21.33 vs FRA:MR4: 68.11

Competitive Comparison of Meridian Bioscience's 12-1 Month Momentum %

For the Diagnostics & Research subindustry, Meridian Bioscience's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Meridian Bioscience's 12-1 Month Momentum % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Meridian Bioscience's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Meridian Bioscience's 12-1 Month Momentum % falls into.



Meridian Bioscience  (FRA:MR4) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Meridian Bioscience  (FRA:MR4) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Meridian Bioscience 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Meridian Bioscience's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Meridian Bioscience (FRA:MR4) Business Description

Traded in Other Exchanges
N/A
Address
3471 River Hills Drive, Cincinnati, OH, USA, 45244
Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.

Meridian Bioscience (FRA:MR4) Headlines

No Headlines